Software-Based Assessment of Well-Aerated Lung at CT for Quantification of Predicted Pulmonary Function in Resected NSCLC.
computer applications software
non-small-cell lung cancer
pulmonary function tests
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
10 Jan 2023
10 Jan 2023
Historique:
received:
17
12
2022
revised:
27
12
2022
accepted:
03
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
Background: To test the agreement between postoperative pulmonary function tests 12 months after surgery (mpo-PFTs) for non-small cell lung cancer (NSCLC) and predicted lung function based on the quantification of well-aerated lung (WAL) at staging CT (sCT). Methods: We included patients with NSCLC who underwent lobectomy or segmentectomy without a history of thoracic radiotherapy or chemotherapy treatment with the availability of PFTs at 12 months follow-up. Postoperative predictive (ppo) lung function was calculated using the resected lobe WAL (the lung volume between −950 and −750 HU) at sCT. The Spearman correlation coefficient (rho) and intraclass correlation coefficient (ICC) were used to the test the agreement between WAL ppo-PFTs and mpo-PFTs. Results: the study included 40 patients (68 years-old, IQR 62−74 years-old; 26/40, 65% males). The WAL ppo-forced expiratory volume in 1 s (FEV1) and the ppo-diffusing capacity of the lung for carbon monoxide (%DLCO) were significantly correlated with corresponding mpo-PFTs (rho = 0.842 and 0.717 respectively; p < 0.001). The agreement with the corresponding mpo-PFTs of WAL ppo-FEV1 was excellent (ICC 0.904), while it was good (ICC 0.770) for WAL ppo-%DLCO. Conclusions: WAL ppo-FEV1 and WAL ppo-%DLCO at sCT showed, respectively, excellent and good agreement with corresponding mpo-PFTs measured 12 months after surgery for NSCLC. WAL is an easy parameter obtained by staging CT that can be used to estimate post-resection lung function for patients with borderline pulmonary function undergoing lung surgery.
Identifiants
pubmed: 36676147
pii: life13010198
doi: 10.3390/life13010198
pmc: PMC9862480
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Comput Assist Tomogr. 2005 Nov-Dec;29(6):819-24
pubmed: 16272858
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221086411
pubmed: 35313752
Diagn Interv Radiol. 2013 Nov-Dec;19(6):447-56
pubmed: 23996838
Curr Radiol Rep. 2023;11(1):1-11
pubmed: 36471674
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21
pubmed: 28881918
Eur J Cardiothorac Surg. 2016 Apr;49(4):1075-82
pubmed: 26248634
Tomography. 2022 Nov 25;8(6):2828-2838
pubmed: 36548528
Chest. 1995 Jul;108(1):68-72
pubmed: 7606994
AJR Am J Roentgenol. 2004 Jan;182(1):73-8
pubmed: 14684515
J Thorac Dis. 2020 Oct;12(10):5269-5280
pubmed: 33209361
Radiology. 2020 Aug;296(2):E86-E96
pubmed: 32301647
Chest. 2013 May;143(5 Suppl):e278S-e313S
pubmed: 23649443
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
Radiology. 2008 Mar;246(3):935-40
pubmed: 18235106
Anesth Analg. 2021 Dec 1;133(6):1633-1641
pubmed: 34633993
Clin Chest Med. 2020 Mar;41(1):1-24
pubmed: 32008623
Eur Respir J. 2009 Jul;34(1):17-41
pubmed: 19567600
Radiology. 1999 May;211(2):541-7
pubmed: 10228540
Eur J Radiol. 2020 Jan;122:108748
pubmed: 31775082
J Comput Assist Tomogr. 1991 Sep-Oct;15(5):742-9
pubmed: 1885791
PLoS One. 2021 Jul 13;16(7):e0254550
pubmed: 34255793
Diagnostics (Basel). 2022 Jun 20;12(6):
pubmed: 35741310